These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3877311)

  • 1. Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat.
    Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1985 Aug; 23(2):303-7. PubMed ID: 3877311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings.
    Swerdlow NR; Vaccarino FJ; Amalric M; Koob GF
    Pharmacol Biochem Behav; 1986 Jul; 25(1):233-48. PubMed ID: 2875470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat.
    Swerdlow NR; Vaccarino FJ; Koob GF
    Pharmacol Biochem Behav; 1985 Sep; 23(3):499-501. PubMed ID: 4048244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neural substrates of apomorphine-stimulated locomotor activity following denervation of the nucleus accumbens.
    Swerdlow NR; Koob GF
    Life Sci; 1984 Dec; 35(25):2537-44. PubMed ID: 6096659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine.
    Pulvirenti L; Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1991 Dec; 40(4):841-5. PubMed ID: 1687766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens.
    Swerdlow NR; Swanson LW; Koob GF
    Brain Res; 1984 Jul; 306(1-2):141-8. PubMed ID: 6087974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation.
    Koob GF; Swerdlow N; Seeligson M; Eaves M; Sutton R; Rivier J; Vale W
    Neuroendocrinology; 1984 Nov; 39(5):459-64. PubMed ID: 6096752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus.
    Swerdlow NR; Amalric M; Koob GF
    Pharmacol Biochem Behav; 1987 Apr; 26(4):765-9. PubMed ID: 3110795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat.
    Vaccarino FJ; Amalric M; Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1986 Jan; 24(1):61-5. PubMed ID: 3080760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral activation by CRF: evidence for the involvement of the ventral forebrain.
    Tazi A; Swerdlow NR; LeMoal M; Rivier J; Vale W; Koob GF
    Life Sci; 1987 Jul; 41(1):41-9. PubMed ID: 3496511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia innominata: critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat.
    Swerdlow NR; Swanson LW; Koob GF
    Neurosci Lett; 1984 Sep; 50(1-3):19-24. PubMed ID: 6493625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test.
    Britton KT; Lee G; Koob GF
    Psychopharmacology (Berl); 1988; 94(3):306-11. PubMed ID: 3128805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of amphetamine-induced locomotor activity by injection of carbachol into the anterior hypothalamic/preoptic area: pharmacological and electrophysiological studies in the rat.
    Brudzynski SM; Mogenson GJ
    Brain Res; 1986 Jun; 376(1):47-56. PubMed ID: 3719373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA, kainic acid, and N-methyl-D-aspartic acid stimulate locomotor activity after injection into the substantia innominata/lateral preoptic area.
    Shreve PE; Uretsky NJ
    Pharmacol Biochem Behav; 1989 Sep; 34(1):101-6. PubMed ID: 2696980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions.
    Hooks MS; Jones GH; Liem BJ; Justice JB
    Pharmacol Biochem Behav; 1992 Nov; 43(3):815-23. PubMed ID: 1448477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low doses of corticotropin-releasing factor potentiate amphetamine-induced stereotyped behavior.
    Cole BJ; Koob GF
    Psychopharmacology (Berl); 1989; 99(1):27-33. PubMed ID: 2506602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central effects of corticotropin releasing factor (CRF): evidence for similar interactions with environmental novelty and with caffeine.
    Britton DR; Indyk E
    Psychopharmacology (Berl); 1990; 101(3):366-70. PubMed ID: 1972997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
    Lu L; Liu Z; Huang M; Zhang Z
    J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral preoptic and ventral pallidal roles in locomotion and other movements.
    Subramanian S; Reichard RA; Stevenson HS; Schwartz ZM; Parsley KP; Zahm DS
    Brain Struct Funct; 2018 Jul; 223(6):2907-2924. PubMed ID: 29700637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.
    Mele A; Thomas DN; Pert A
    Neuroscience; 1998 Jan; 82(1):43-58. PubMed ID: 9483502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.